Form 4 for TMDX TransMedics Group, Inc.

Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-27 · accession 0000950170-23-005192 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-02-28	2023-02-27	TMDX	Basile Edward M	Dir	S - Sale	$78.06	-5,000	17.8K	-22%	-$390.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-02-27	S	D	1,500	$76.20	21,314	D	—	—	(F1) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $76.00 to $76.54, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
2	Common	Common Stock	2023-02-27	S	D	1,500	$78.17	19,814	D	—	—	(F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $78.00 to $78.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3	Common	Common Stock	2023-02-27	S	D	2,000	$79.38	17,814	D	—	—	(F3) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $79.25 to $79.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.